In addition to EGF/EGFR interactions, the malignant properties of CC cells are enhanced by the SDF/CXCR4 pathway and IL-1β -CXCL5, which also interface with the infiltrating immune compartment of the tumour stroma. The gene discussed is EGF; the disease is cholangiocarcinoma.